ASX: DTR · Five-year financial review

(ASX: DTR) Dateline Resources Financial Review - FY2021~25

Dateline’s FY2021-FY2025 finances span Colorado development and disposal, a focus on Colosseum and renewed equity funding. The latest cash recovery is financing-led; study economics are future scenarios, not the company’s recorded sales or profit.

Years ended 30 June 2021-2025 · A$ million unless stated · Editorial review: 2026-09-28 · MII Research

Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.

FY2025 cash
A$8.945m

Before September capital raising.

Net loss
A$11.729m

Reported annual loss.

Net financing
A$14.026m

Annual financing inflow.

Liabilities
A$4.376m

Includes current loans.

Five years in context

The Colorado sale agreement was signed in June 2023, but ownership transferred in December 2023. The final cash instalment followed in April 2024; production-linked consideration is conditional, not cash already received.

Colosseum scoping-study revenues and project economics depend on assumptions. This financial review keeps them outside statutory revenues, cash balances and realised earnings.

Events behind the numbers

FY2021

Debt-backed expansion

Borrowing proceeds were a major component of the year’s financing inflow.

FY2022

Higher operating and project spending

Operating and investing outflows drew down cash despite substantial financing.

FY2023

Colorado sale agreement

The sale agreement was signed before year-end, with ownership transfer still to follow in December.

FY2024

Transfer and disposal accounting

Colorado ownership transferred and final cash consideration was paid; the statement records a large disposal loss.

FY2025

Option funding and Udu divestment

Option conversions supported cash. Udu consideration includes contingent amounts that are not all cash received.

FINANCIAL REVIEW / 01

Cash recovery is not operating break-even

Cash rose after financing, while operations continued to use cash. The September A$25m raising is subsequent to June and is not added to the balance-date amount.

Closing cash

A$ million

Closing cashCash and equivalents: FY2021 7.092; FY2022 1.936; FY2023 0.929; FY2024 0.849; FY2025 8.94502.55.017.5110.02FY2021FY2022FY2023FY2024FY2025Cash and equivalents, FY2021: 7.092 A$ million7.092Cash and equivalents, FY2022: 1.936 A$ million1.936Cash and equivalents, FY2023: 0.929 A$ million0.929Cash and equivalents, FY2024: 0.849 A$ million0.849Cash and equivalents, FY2025: 8.945 A$ million8.945
Cash and equivalents
A$ million; June balance dates.

AI-generated presentation · values from Consolidated cash and equity; no missing values plotted as zero.

Group equity

A$ million

Group equityTotal equity: FY2021 14.549; FY2022 10.589; FY2023 11.064; FY2024 3.586; FY2025 9.22804.078.1512.2216.29FY2021FY2022FY2023FY2024FY2025Total equity, FY2021: 14.549 A$ million14.549Total equity, FY2022: 10.589 A$ million10.589Total equity, FY2023: 11.064 A$ million11.064Total equity, FY2024: 3.586 A$ million3.586Total equity, FY2025: 9.228 A$ million9.228
Total equity
FY2022 revised; changing portfolio.

AI-generated presentation · values from Consolidated cash and equity; no missing values plotted as zero.

Consolidated cash and equity

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Cash and equivalents7.0921.9360.9290.8498.945
Total equity14.54910.58911.0643.5869.228

FY2022 equity is the revised comparative in the FY2023 statement. Parent-only equity is excluded. Portfolio disposals change the group scope.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

FINANCIAL REVIEW / 02

Disposals and funding change the comparison

The loss narrowed after the large FY2024 disposal charge, but FY2025 also included an exploration impairment. Two stored extracts disagree on its exact amount, so no precise impairment bridge is asserted.

Loss and operating cash

A$ million

Loss and operating cashReported loss after tax: FY2021 (5.894); FY2022 (13.904); FY2023 (11.123); FY2024 (17.237); FY2025 (11.729) | Net operating cash flow: FY2021 (2.313); FY2022 (10.942); FY2023 (13.717); FY2024 (5.644); FY2025 (5.274)-18.27-13.19-8.1-3.022.07FY2021FY2022FY2023FY2024FY2025Reported loss after tax, FY2021: (5.894) A$ millionReported loss after tax, FY2022: (13.904) A$ millionReported loss after tax, FY2023: (11.123) A$ millionReported loss after tax, FY2024: (17.237) A$ millionReported loss after tax, FY2025: (11.729) A$ millionNet operating cash flow, FY2021: (2.313) A$ millionNet operating cash flow, FY2022: (10.942) A$ millionNet operating cash flow, FY2023: (13.717) A$ millionNet operating cash flow, FY2024: (5.644) A$ millionNet operating cash flow, FY2025: (5.274) A$ million
Reported loss after taxNet operating cash flow
Different accrual and cash bases.

AI-generated presentation · values from Statutory loss and operating cash; no missing values plotted as zero.

Investment and funding flows

A$ million

Investment and funding flowsNet investing cash flow: FY2021 (1.924); FY2022 (9.116); FY2023 (1.746); FY2024 1.295; FY2025 (0.656) | Net financing cash flow: FY2021 11.171; FY2022 14.902; FY2023 14.456; FY2024 4.270; FY2025 14.026-10.56-3.473.6110.717.78FY2021FY2022FY2023FY2024FY2025Net investing cash flow, FY2021: (1.924) A$ millionNet investing cash flow, FY2022: (9.116) A$ millionNet investing cash flow, FY2023: (1.746) A$ millionNet investing cash flow, FY2024: 1.295 A$ millionNet investing cash flow, FY2025: (0.656) A$ millionNet financing cash flow, FY2021: 11.171 A$ millionNet financing cash flow, FY2022: 14.902 A$ millionNet financing cash flow, FY2023: 14.456 A$ millionNet financing cash flow, FY2024: 4.270 A$ millionNet financing cash flow, FY2025: 14.026 A$ million
Net investing cash flowNet financing cash flow
Positive investing in FY2024 includes divestment cash.

AI-generated presentation · values from Investing and financing cash; no missing values plotted as zero.

Statutory loss and operating cash

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Reported loss after tax(5.894)(13.904)(11.123)(17.237)(11.729)
Net operating cash flow(2.313)(10.942)(13.717)(5.644)(5.274)

FY2022 uses the FY2023 revised comparative. Series reflects the group as reported in each year, not a constant portfolio or unchanged production base.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

Investing and financing cash

A$ million

MetricFY2021FY2022FY2023FY2024FY2025
Net investing cash flow(1.924)(9.116)(1.746)1.295(0.656)
Net financing cash flow11.17114.90214.4564.27014.026

Financing combines equity and debt transactions. Positive FY2024 investing cash includes disposal proceeds; it is not mine operating revenue.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

FINANCIAL REVIEW / 03

Remaining obligations and conditional proceeds

Related-party and short-term liabilities remain despite the absence of long-term loans. The going-concern discussion depends on executing strategy and access to funding, and the auditor highlighted both funding and Fiji-tenement matters.

Liabilities and their current loan components

A$ million

Liabilities and their current loan componentsTotal liabilities: FY2024 6.443; FY2025 4.376 | Current related-party financial liabilities: FY2024 4.129; FY2025 2.474 | Current short-term loans: FY2024 1.286; FY2025 0.46501.83.615.417.22FY2024FY2025Total liabilities, FY2024: 6.443 A$ millionTotal liabilities, FY2025: 4.376 A$ millionCurrent related-party financial liabilities, FY2024: 4.129 A$ millionCurrent related-party financial liabilities, FY2025: 2.474 A$ millionCurrent short-term loans, FY2024: 1.286 A$ millionCurrent short-term loans, FY2025: 0.465 A$ million
Total liabilitiesCurrent related-party financial liabilitiesCurrent short-term loans
Components overlap with total; do not add the three series.

AI-generated presentation · values from Recent liability profile; no missing values plotted as zero.

Recent liability profile

A$ million

MetricFY2024FY2025
Current related-party financial liabilities4.1292.474
Current short-term loans1.2860.465
Total liabilities6.4434.376

Component loans are included in total liabilities. No long-term loans does not mean no debt: current loans and related-party liabilities remain.

Source: Annual-report extractions; report editions are listed once in the consolidated source registry.

Reading the figures

  • FY2025 impairment differs between the extracted P&L A$4,646,792 and the Matai narrative A$4,676,792; exact amount remains unresolved.
  • FY2022 comparative revisions and subsequent asset sales prevent a constant-portfolio interpretation.
  • Udu milestones, Colorado contingent payments and Colosseum study revenues are not treated as received cash.
  • Prepared from existing year-by-year extraction records only. No raw-source retrieval, database query, financial web research or MiniMax call. Primary-author review, not an independent original-document audit; published.

Annual-report source registry

  • Dateline Resources - Amended Annual ReportExisting annual extraction, including separately identified historical comparatives.
  • Dateline Resources - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
  • Dateline Resources - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
  • Dateline Resources - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
  • Dateline Resources - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.

Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.

Sources, copyright and independence

The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.

Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.

AI-led method

This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.

Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.

Information notice

This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.

It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.

Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.

Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.